Cargando…
Fibrosing interstitial lung diseases: knowns and unknowns
Patients with certain types of fibrosing interstitial lung disease (ILD) are at risk of developing a progressive phenotype characterised by self-sustaining fibrosis, decline in lung function, worsening quality of life, and early mortality. It has been proposed that such progressive fibrosing ILDs, w...
Autores principales: | Cottin, Vincent, Wollin, Lutz, Fischer, Aryeh, Quaresma, Manuel, Stowasser, Susanne, Harari, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489101/ https://www.ncbi.nlm.nih.gov/pubmed/30814139 http://dx.doi.org/10.1183/16000617.0100-2018 |
Ejemplares similares
-
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019) -
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021) -
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022) -
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019) -
The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)